Trial Profile
The Use of Bevacizumab as a Modulator of Wound Healing Following Trabeculectomy Surgery: A Single Centre Randomised Controlled Phase III Pilot Study
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 19 Aug 2021
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Dexamethasone; Fluorouracil
- Indications Glaucoma; Wounds
- Focus Therapeutic Use
- Acronyms RAFTS
- 16 Aug 2021 Status changed from active, no longer recruiting to completed.
- 27 Jul 2020 This trial is discontinued (Global End Date: 05 Sep 2019), according to European Clinical Trials Database record.
- 04 May 2020 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently (last verified Aug 2018).